Arthur David J. 4
4 · Salarius Pharmaceuticals, Inc. · Filed May 5, 2022
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-05-03$0.19/sh+10,000$1,863→ 259,674 total
Footnotes (1)
- [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.